News
Allbirds, Inc. (BIRD) Reports Q1 Loss, Tops Revenue Estimates
Allbirds, Inc. (BIRD) came out with a quarterly loss of $2.73 per share versus the Zacks Consensus Estimate of a loss of $3.85. This compares to loss of $3.60 per share a year ago. These figures are
Applied Optoelectronics (AAOI) Reports Q1 Loss, Tops Revenue Estimates
Applied Optoelectronics (AAOI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.31 per share a year ago. These
Trex (TREX) Tops Q1 Earnings and Revenue Estimates
Trex (TREX) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.82 per share a year ago. These figures are
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2025, Solventum (SOLV) reported revenue of $2.07 billion, up 2.7% over the same period last year. EPS came in at $1.34, compared to $2.08 in the year-ago quarter.
The
Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics
Collegium Pharmaceutical (COLL) reported $177.76 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 22.7%. EPS of $1.49 for the same period compares to
Microchip Technology (MCHP) Q4 Earnings and Revenues Beat Estimates
Microchip Technology (MCHP) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.57 per share a year ago
Compared to Estimates, Olo (OLO) Q1 Earnings: A Look at Key Metrics
For the quarter ended March 2025, Olo Inc. (OLO) reported revenue of $80.68 million, up 21.3% over the same period last year. EPS came in at $0.07, compared to $0.05 in the year-ago quarter.
The
Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say
Insulet (PODD) reported $569 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 28.8%. EPS of $1.02 for the same period compares to $0.73 a year ago.
The
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year
Research Solutions Inc. (RSSS) Meets Q3 Earnings Estimates
Research Solutions Inc. (RSSS) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate. This compares to break-even earnings per share a year ago. These
Pacira (PCRX) Reports Q1 Earnings: What Key Metrics Have to Say
Pacira (PCRX) reported $168.92 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.1%. EPS of $0.62 for the same period compares to $0.62 a year ago.
The
DoubleVerify Holdings (DV) Q1 Earnings Miss Estimates
DoubleVerify Holdings (DV) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.04 per share a year ago
Akamai Technologies (AKAM) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended March 2025, Akamai Technologies (AKAM) reported revenue of $1.02 billion, up 2.9% over the same period last year. EPS came in at $1.70, compared to $1.64 in the year-ago
Dropbox (DBX) Q1 Earnings and Revenues Surpass Estimates
Dropbox (DBX) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.58 per share a year ago. These figures are
Leslie's, Inc. (LESL) Reports Q2 Loss, Misses Revenue Estimates
Leslie's, Inc. (LESL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.17 per share a year ago. These figures are
Here's What Key Metrics Tell Us About Lyft (LYFT) Q1 Earnings
For the quarter ended March 2025, Lyft (LYFT) reported revenue of $1.45 billion, up 13.5% over the same period last year. EPS came in at $0.19, compared to $0.15 in the year-ago quarter.
The
Federal Realty Investment Trust (FRT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2025, Federal Realty Investment Trust (FRT) reported revenue of $309.15 million, up 6.1% over the same period last year. EPS came in at $1.70, compared to $0.66 in the
Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates
Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.42 per share a year ago. These
JFrog Ltd. (FROG) Q1 Earnings and Revenues Surpass Estimates
JFrog Ltd. (FROG) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.16 per share a year ago. These figures
Sensata (ST) Q1 Earnings and Revenues Beat Estimates
Sensata (ST) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.89 per share a year ago. These figures are
Xponential Fitness (XPOF) Reports Q1 Loss, Tops Revenue Estimates
Xponential Fitness (XPOF) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of $0.15. This compares to earnings of $0.16 per share a year ago. These figures are
ZipRecruiter, Inc. (ZIP) Reports Q1 Loss, Tops Revenue Estimates
ZipRecruiter, Inc. (ZIP) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.07 per share a year ago. These figures
BioLife Solutions, Inc. (BLFS) Q1 Earnings and Revenues Beat Estimates
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to loss of $0.19 per share a year
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.43 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.46 per share a year ago. These figures are
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
Cardiff Oncology (CRDF) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.22 per share a year ago. These figures


